Related Experiment Videos

Expression of genetic damage induced by alkylating agents in germ cells of female mice

Mutation Research
|February 22, 1982
PubMed

Insights

Alkylating agents like Trenimon (TR) cause meiotic non-disjunction and structural aberrations in mouse oocytes. These genetic defects correlate with embryonic mortality, highlighting the reproductive risks of these chemicals.

Area of Science:

  • Reproductive toxicology
  • Cytogenetics
  • Developmental biology

Background:

  • Alkylating agents are known mutagens with potential reproductive toxicity.
  • Understanding their effects on meiosis and early embryogenesis is crucial for risk assessment.

Purpose of the Study:

  • To analyze meiotic non-disjunction and structural aberrations in mouse oocytes following exposure to alkylating agents.
  • To investigate the relationship between these cytogenetic aberrations and dominant lethal effects during early embryogenesis.

Main Methods:

  • Comparative cytogenetic analysis of unfertilized MII oocytes and first-cleavage metaphases in mice.
  • Pre-ovulatory treatment with Trenimon (TR) and cyclophosphamide (CYC).
  • Dominant lethal assay to assess embryonic mortality.

Main Results:

  • Trenimon (TR) induced significant meiotic non-disjunction and a strong clastogenic effect at first cleavage, with 51.79% of cells showing structural aberrations at 0.25 mg/kg.
  • A high frequency of aberrant eggs (63.39%) correlated with embryonic mortality (55.17%).
  • Cyclophosphamide (CYC) showed a slight increase in meiotic non-disjunction but a high incidence of dominant lethal effects (58.94%).

Conclusions:

  • Trenimon-induced DNA lesions require a round of DNA replication to form structural aberrations.
  • The frequency of cytogenetic aberrations in oocytes is quantitatively linked to embryonic lethality.
  • Alkylating agents pose significant risks to meiotic integrity and early embryonic development.

Related Concept Videos